Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion type Assertion NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_head.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_provenance.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion evidence source_evidence_literature NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_provenance.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion SIO_000772 16229808 NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_provenance.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion wasDerivedFrom lhgdn-20090331 NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_provenance.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion wasGeneratedBy ECO_0000203 NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_provenance.